SCHEMBL10280559

SCHEMBL10280559

CCCCC(CC)COC(=O)CCSc1ccc(OCc2ccccc2)cc1N=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ ATM Q13315 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ CA2 P00918 1/20 0.41
▸ MAPK1 P28482 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ LPAR1 Q92633 2/20 0.38
▸ LPAR3 Q9UBY5 2/20 0.38
▸ PRSS1 P07477 1/20 0.37
▸ PRSS2 P07478 1/20 0.37
▸ PRSS3 P35030 1/20 0.37
▸ PTGES O14684 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ NMT1 P30419 1/20 0.36
▸ CTRC Q99895 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10279989 0.94 TDP1 (0.42) TDP1CYP3A4TSHRATMALDH1A1
SCHEMBL1391027 0.88 CYP3A4 (0.43) TDP1CYP3A4TSHRATMALDH1A1
SCHEMBL1391363 0.87 CYP3A4 (0.44) TDP1CYP3A4TSHRATMALDH1A1
SCHEMBL1390971 0.85 CYP3A4 (0.40) TDP1CYP3A4TSHRATMALDH1A1
SCHEMBL1390443 0.84 CYP3A4 (0.41) TDP1CYP3A4TSHRATMALDH1A1
SCHEMBL7928273 0.81 LTA4H (0.46) TDP1CYP3A4TSHRATMALDH1A1
SCHEMBL1390739 0.80 ALDH1A1 (0.39) TDP1CYP3A4TSHRATMALDH1A1
SCHEMBL1390738 0.80 ALDH1A1 (0.39) TDP1CYP3A4TSHRATMALDH1A1
SCHEMBL10279988 0.79 ALDH1A1 (0.47) TDP1CYP3A4TSHRATMALDH1A1
SCHEMBL1390850 0.79 ALDH1A1 (0.40) TDP1CYP3A4TSHRATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120010247-A1 BICYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010247-A1 BICYCLIC COMPOUND ACACA, CPT1B, ACACB TDP1 4400/4885CYP3A4 3464/4885TSHR 3927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback